8 Stock Picks to Bet on Beating Cancer

These biotechnology companies are making important strides in treating many forms of cancer.

A cancer diagnosis was once a death sentence -- particularly if you were diagnosed when the disease was at a late stage. But experts say that recent clinical trials and treatment breakthroughs show real promise. That's given patients new hope -- and caused investors to bid up the prices of biotechnology companies that specialize in cancer cures.

Although only a handful of these biotech companies are currently profitable, investor optimism is warranted, says analyst Geoffrey Porges, of Bernstein Research. Both government and industry have poured enormous sums over the past decade into researching how cancers develop and spread, vastly improving the development of effective treatments.

Subscribe to Kiplinger’s Personal Finance

Be a smarter, better informed investor.

Save up to 74%

Sign up for Kiplinger’s Free E-Newsletters

Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.

Profit and prosper with the best of expert advice - straight to your e-mail.

Sign up

To continue reading this article
please register for free

This is different from signing in to your print subscription

Why am I seeing this? Find out more here

Kathy Kristof
Contributing Editor, Kiplinger's Personal Finance
Kristof, editor of SideHusl.com, is an award-winning financial journalist, who writes regularly for Kiplinger's Personal Finance and CBS MoneyWatch. She's the author of Investing 101, Taming the Tuition Tiger and Kathy Kristof's Complete Book of Dollars and Sense. But perhaps her biggest claim to fame is that she was once a Jeopardy question: Kathy Kristof replaced what famous personal finance columnist, who died in 1991? Answer: Sylvia Porter.